» Articles » PMID: 27002844

Emerging Concepts of T Cell Metabolism As a Target of Immunotherapy

Overview
Journal Nat Immunol
Date 2016 Mar 23
PMID 27002844
Citations 183
Authors
Affiliations
Soon will be listed here.
Abstract

T cells have a pivotal protective role in defense against infection and cancer but also are instrumental in the development of many autoimmune diseases. The regulation of nutrient uptake and utilization in T cells is critically important for the control of their differentiation, and manipulating metabolic pathways in these cells can alter their function and longevity. While the importance of T cell metabolic remodeling in different physiological settings is not fully understood, there is a growing realization that inappropriate metabolic remodeling underlies many aberrant immune responses and that manipulating cellular metabolism can beneficially enhance or temper immunity. Here we comment on the basic metabolic pathways in T cells, followed by a discussion on up-to-date findings about the relationship between metabolism and T cell function and longevity. Furthermore, we expand on potential approaches and applications in which T cells might be manipulated by the reprogramming of metabolic pathways for therapeutic purposes.

Citing Articles

Impact of immune cell metabolism on membranous nephropathy and prospective therapy.

Duan X, Lv X, Wang X, Zhang Y, Hu Y, Li H Commun Biol. 2025; 8(1):405.

PMID: 40065158 PMC: 11893770. DOI: 10.1038/s42003-025-07816-3.


Immunometabolism of Liver Xenotransplantation and Prospective Solutions.

Deng S, Zhang Y, Shen S, Li C, Qin C Adv Sci (Weinh). 2025; 12(9):e2407610.

PMID: 39912334 PMC: 11884532. DOI: 10.1002/advs.202407610.


Neoantigen mRNA vaccines and AA receptor antagonism: A strategy to enhance T cell immunity.

Imani S, Jabbarzadeh Kaboli P, Babaeizad A, Maghsoudloo M Hum Vaccin Immunother. 2025; 21(1):2458936.

PMID: 39882781 PMC: 11784654. DOI: 10.1080/21645515.2025.2458936.


Metabolic Signaling in the Tumor Microenvironment.

Clay R, Li K, Jin L Cancers (Basel). 2025; 17(1.

PMID: 39796781 PMC: 11719658. DOI: 10.3390/cancers17010155.


Role of T cell metabolism in brain tumor development: a genetic and metabolic approach.

Yang B, Li Z, Li P, Liang B, Liu Y, Feng E BMC Neurol. 2025; 25(1):12.

PMID: 39780065 PMC: 11708232. DOI: 10.1186/s12883-024-04015-1.


References
1.
Wang R, Dillon C, Shi L, Milasta S, Carter R, Finkelstein D . The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 2011; 35(6):871-82. PMC: 3248798. DOI: 10.1016/j.immuni.2011.09.021. View

2.
Wang Y, Wang X, Subjeck J, Shrikant P, Kim H . Temsirolimus, an mTOR inhibitor, enhances anti-tumour effects of heat shock protein cancer vaccines. Br J Cancer. 2011; 104(4):643-52. PMC: 3049595. DOI: 10.1038/bjc.2011.15. View

3.
Berod L, Friedrich C, Nandan A, Freitag J, Hagemann S, Harmrolfs K . De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat Med. 2014; 20(11):1327-33. DOI: 10.1038/nm.3704. View

4.
Munn D, Sharma M, Baban B, Harding H, Zhang Y, Ron D . GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity. 2005; 22(5):633-42. DOI: 10.1016/j.immuni.2005.03.013. View

5.
Gerriets V, Kishton R, Nichols A, Macintyre A, Inoue M, Ilkayeva O . Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J Clin Invest. 2014; 125(1):194-207. PMC: 4382238. DOI: 10.1172/JCI76012. View